NFKB1 and experimental autoimmune encephalomyelitis: In both glial cells the activation of AHR by its ligands limits NF-κB activation in a SOCS2-dependent manner suppressing NF-κB control of glial responses, as demonstrated in a model of experimental autoimmune encephalomyelitis (EAE).